Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of report (Date of earliest event reported): October 10, 2017


Amedica Corporation

(Exact name of registrant as specified in its charter)


Delaware   001-33624   84-1375299

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification No.)


1885 West 2100 South

Salt Lake City, UT

(Address of principal executive offices)   (Zip Code)


Registrant’s telephone number, including area code: (801) 839-3500



(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.07 Submission of Matters to a Vote of Security Holders


A Special Meeting of Stockholders (the “Special Meeting”) of Amedica Corporation (the “Company”) was held on October 10, 2017. At the Special Meeting, the stockholders voted on the following two proposals and cast their votes as described below.


Proposal No. 1: A proposal to approve an amendment to the Company’s Restated Certificate of Incorporation to effectuate a reverse stock split of the Company’s issued and outstanding shares of Common Stock at a ratio of between 1-for-2 and 1-for-15, inclusive, which ratio will be selected at the sole discretion of our Board of Directors at any whole number in the above range, with any fractional shares that would otherwise be issued as a result of the reverse stock split being rounded up to the nearest whole share (the “Reverse Stock Split”); provided, that our Board of Directors may abandon the Reverse Stock Split in its sole discretion. This proposal was approved.


For  Against   Abstain   Broker Non-vote 
18,211,006   6,343,473    168,131    0 


Proposal No. 2: A proposal to approve one or more adjournments of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt one or more of the foregoing Proposals. This proposal was approved.


For  Against   Abstain   Broker Non-vote 
18,552,800   5,927,971    241,840    0 






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: October 11, 2017 /s/ B. Sonny Bal

B. Sonny Bal

President and Chief Executive Officer